|
US4181803A
(en)
|
1973-12-14 |
1980-01-01 |
Eisai Co., Ltd. |
Propiophenone derivatives and preparation thereof
|
|
EP0110091B1
(de)
|
1982-10-27 |
1987-01-21 |
Degussa Aktiengesellschaft |
2-Amino-3-Acylamino-6-benzylamino-pyridin-Derivate mit anti-epileptischer Wirkung
|
|
DE3337593A1
(de)
|
1982-10-27 |
1984-05-03 |
Degussa Ag, 6000 Frankfurt |
2-amino-3-acylamino-6-benzylamino-pyridin-derivate mit antiepileptischer wirkung
|
|
DE3665538D1
(en)
|
1985-01-23 |
1989-10-19 |
Asta Pharma Ag |
Synergistic combination of flupirtin and non-steroidal anti-phlogistics
|
|
EP0193056B1
(de)
|
1985-02-23 |
1989-06-07 |
ASTA Pharma Aktiengesellschaft |
Kombination von Flupirtin und anticholinergisch wirkenden Spasmolytika
|
|
DE3604575A1
(de)
|
1985-02-23 |
1986-08-28 |
Degussa Ag, 6000 Frankfurt |
Kombination von flupirtin und anticholinergisch wirkenden spasmolytika
|
|
JP2583067B2
(ja)
|
1987-08-04 |
1997-02-19 |
住友化学工業株式会社 |
モノアゾ化合物およびそれを用いて疎水性繊維材料を染色または捺染する方法
|
|
GB8800199D0
(en)
|
1988-01-06 |
1988-02-10 |
Beecham Group Plc |
Pharmaceutical preparation
|
|
MC2029A1
(fr)
|
1988-05-16 |
1990-04-25 |
Asta Pharma Ag |
(n-heterocyclyl)-3 diamino-2,6 pyridines substituees et leurs n-oxydes,preparation de ces composes et leur application comme medicaments
|
|
US5629307A
(en)
|
1989-10-20 |
1997-05-13 |
Olney; John W. |
Use of ibogaine in reducing excitotoxic brain damage
|
|
US6004945A
(en)
|
1990-05-10 |
1999-12-21 |
Fukunaga; Atsuo F. |
Use of adenosine compounds to relieve pain
|
|
IN172468B
(OSRAM)
|
1990-07-14 |
1993-08-14 |
Asta Medica Ag |
|
|
US5643921A
(en)
|
1990-09-26 |
1997-07-01 |
E.R. Squibb & Sons, Inc. |
Cardiopulmonary bypass and organ transplant using a potassium channel activator
|
|
US5234947A
(en)
|
1991-11-07 |
1993-08-10 |
New York University |
Potassium channel activating compounds and methods of use thereof
|
|
DE4200259A1
(de)
|
1992-01-08 |
1993-07-15 |
Asta Medica Ag |
Neue 1,2,4-triaminobenzol-derivate und verfahren zu deren herstellung
|
|
US5262419A
(en)
|
1992-06-11 |
1993-11-16 |
E. R. Squibb & Sons, Inc. |
Method for the prophylaxis and/or treatment of ulcerative gastrointestinal conditions using a potassium channel activator
|
|
CA2115792C
(en)
|
1993-03-05 |
2005-11-01 |
David J. Mayer |
Method for the treatment of pain
|
|
US5428039A
(en)
|
1994-02-20 |
1995-06-27 |
The Center For Innovative Technology |
Method for electively achieving reversible hyperpolarized cardiac arrest
|
|
FI971334A7
(fi)
*
|
1994-08-03 |
1997-04-01 |
Asta Medica Ag |
Indoli-, indatsoli-, pyridopyrroli- ja pyridopyratsolijohdannaiset, jo illa on antiastmaattinen, antiallerginen, anti-inflammatorinen ja immu nomoduloiva vaikutus
|
|
DE69434794T2
(de)
|
1994-09-22 |
2007-07-12 |
Smith, Richard Alan, La Jolla |
Kombination von dextromethorphan mit quinidine oder quinine sulfat zur behandlung verschiedener refraktärer störungen
|
|
US5679706A
(en)
|
1994-09-30 |
1997-10-21 |
Bristol-Myers Squibb Company |
Combination of a potassium channel activator and an antiarrhythmic agent
|
|
DE69534341T2
(de)
|
1994-12-12 |
2006-05-24 |
Omeros Corp., Seattle |
Bespüllungslösung und deren verwendung zur perioperativen hemmung von schmerzen, entzündungen und spasmen an einer wunde
|
|
DE19539861A1
(de)
|
1995-10-26 |
1997-04-30 |
Asta Medica Ag |
Verwendung von 4-Amino-4-(4-fluorbenzylamino)-1-ethoxy-carbonylaminobenzen zur Prophylaxe und Behandlung der Folgen der akuten und chronischen zerebralen Minderdurchblutung sowie neurodegenerativer Erkrankungen
|
|
DE19701694A1
(de)
|
1997-01-20 |
1998-07-23 |
Asta Medica Ag |
Neue Modifikationen des 2-Amino-4-(4-fluorbenzylamino)-l-ethoxycarbonyl-aminobenzen sowie Verfahren zu ihrer Herstellung
|
|
IN188411B
(OSRAM)
*
|
1997-03-27 |
2002-09-21 |
Yuhan Corp |
|
|
US5760007A
(en)
|
1997-07-16 |
1998-06-02 |
Ortho Pharmaceutical Corporation |
Anticonvulsant derivatives useful in treating neuropathic pain
|
|
DE69832176T2
(de)
|
1997-08-08 |
2006-08-03 |
Chugai Seiyaku K.K. |
Arzneimittel gegen diabetes-komplikationen
|
|
US6265417B1
(en)
|
1997-12-18 |
2001-07-24 |
Abbott Laboratories |
Potassium channel openers
|
|
US6593335B1
(en)
|
1997-12-18 |
2003-07-15 |
Abbott Laboratories |
Potassium channel openers
|
|
US6211171B1
(en)
|
1998-05-19 |
2001-04-03 |
Dalhousie University |
Use of antidepressants for local analgesia
|
|
JP3441970B2
(ja)
|
1998-06-30 |
2003-09-02 |
株式会社サミー |
豆腐の製造方法及び製造装置
|
|
JP2000143510A
(ja)
|
1998-11-16 |
2000-05-23 |
Taisho Pharmaceut Co Ltd |
外用組成物
|
|
CZ20012113A3
(cs)
|
1998-12-14 |
2001-11-14 |
Cellegy Pharmaceuticals, Inc. |
Prostředky a způsoby pro léčbu onemocnění anorektální oblasti
|
|
US6281211B1
(en)
|
1999-02-04 |
2001-08-28 |
Euro-Celtique S.A. |
Substituted semicarbazides and the use thereof
|
|
GB9903476D0
(en)
|
1999-02-17 |
1999-04-07 |
Zeneca Ltd |
Therapeutic agents
|
|
CA2359485A1
(en)
|
1999-03-10 |
2000-09-14 |
Warner-Lambert Company |
Analgesic compositions comprising anti-epileptic compounds and methods of using same
|
|
US6436923B1
(en)
|
1999-03-17 |
2002-08-20 |
Signal Pharmaceuticals, Inc. |
Compounds and methods for modulation of estrogen receptors
|
|
AT409083B
(de)
|
1999-04-01 |
2002-05-27 |
Sanochemia Pharmazeutika Ag |
Pharmazeutische, tolperison enthaltende zubereitung zur oralen verabreichung
|
|
US6610324B2
(en)
|
1999-04-07 |
2003-08-26 |
The Mclean Hospital Corporation |
Flupirtine in the treatment of fibromyalgia and related conditions
|
|
GB9915414D0
(en)
|
1999-07-01 |
1999-09-01 |
Glaxo Group Ltd |
Medical use
|
|
AU773304B2
(en)
|
1999-07-06 |
2004-05-20 |
Eli Lilly And Company |
Selective iGluR5 receptor antagonists for the treatment of migraine
|
|
US6472165B1
(en)
|
1999-08-03 |
2002-10-29 |
Arzneimittelwerk Dresden Gmbh |
Modulatory binding site in potassium channels for screening and finding new active ingredients
|
|
US6495550B2
(en)
|
1999-08-04 |
2002-12-17 |
Icagen, Inc. |
Pyridine-substituted benzanilides as potassium ion channel openers
|
|
ATE380176T1
(de)
|
1999-08-04 |
2007-12-15 |
Icagen Inc |
Benzanilide als öffner des kaliumkanals
|
|
US6326385B1
(en)
|
1999-08-04 |
2001-12-04 |
Icagen, Inc. |
Methods for treating or preventing pain
|
|
US6117900A
(en)
|
1999-09-27 |
2000-09-12 |
Asta Medica Aktiengesellschaft |
Use of retigabine for the treatment of neuropathic pain
|
|
US6383511B1
(en)
|
1999-10-25 |
2002-05-07 |
Epicept Corporation |
Local prevention or amelioration of pain from surgically closed wounds
|
|
US6538004B2
(en)
|
2000-03-03 |
2003-03-25 |
Abbott Laboratories |
Tricyclic dihydropyrazolone and tricyclic dihydroisoxazolone potassium channel openers
|
|
US20020015730A1
(en)
|
2000-03-09 |
2002-02-07 |
Torsten Hoffmann |
Pharmaceutical formulations and method for making
|
|
TWI287984B
(en)
|
2000-10-17 |
2007-10-11 |
Wyeth Corp |
Pharmaceutical composition for modulating bladder function
|
|
US6589986B2
(en)
|
2000-12-20 |
2003-07-08 |
Wyeth |
Methods of treating anxiety disorders
|
|
WO2002064574A2
(en)
*
|
2001-02-07 |
2002-08-22 |
Ortho-Mcneil Pharmaceutical, Inc. |
Pyridoarylphenyl oxazolidinone antibacterials, and related compositions and methods
|
|
US6469042B1
(en)
|
2001-02-20 |
2002-10-22 |
Bristol-Myers Squibb Company |
Fluoro oxindole derivatives as modulators if KCNQ potassium channels
|
|
AU2002338333A1
(en)
|
2001-04-04 |
2002-10-21 |
Wyeth |
Methods for treating hyperactive gastric motility
|
|
GB0121214D0
(en)
|
2001-08-31 |
2001-10-24 |
Btg Int Ltd |
Synthetic method
|
|
US6831087B2
(en)
*
|
2001-11-09 |
2004-12-14 |
Hoffmann-La Roche Inc. |
Pyridine substituted isoquinoline derivatives
|
|
US7375222B2
(en)
*
|
2002-02-05 |
2008-05-20 |
Astellas Pharma Inc. |
2,4,6-Triamino-1,3,5-triazine derivative
|
|
AU2003202115A1
(en)
|
2002-02-12 |
2003-09-04 |
Pfizer Inc. |
Non-peptide compounds affecting the action of gonadotropin-releasing hormone (gnrh)
|
|
WO2003097586A1
(en)
|
2002-05-17 |
2003-11-27 |
Janssen Pharmaceutica N.V. |
Aminotetralin-derived urea modulators of vanilloid vr1 receptor
|
|
WO2003106454A1
(en)
|
2002-06-12 |
2003-12-24 |
Orchid Chemicals & Pharmaceuticals Ltd |
1h-isoquinoline-oxazolidinone derivaties and their use as antibacterial agents
|
|
AUPS312602A0
(en)
|
2002-06-21 |
2002-07-18 |
James Cook University |
Organ arrest, protection, preservation and recovery
|
|
US7419981B2
(en)
|
2002-08-15 |
2008-09-02 |
Pfizer Inc. |
Synergistic combinations of an alpha-2-delta ligand and a cGMP phosphodieterse 5 inhibitor
|
|
EP1581510A4
(en)
|
2002-11-22 |
2006-08-30 |
Bristol Myers Squibb Co |
1-ARYL-2-HYDROXYETHYLAMIDEALS CALIUM CHANNEL OPENER
|
|
AU2003303484C1
(en)
|
2002-12-23 |
2012-06-14 |
Icagen, Inc. |
Quinazolinones as potassium channel modulators
|
|
NZ540446A
(en)
|
2002-12-27 |
2008-03-28 |
Lundbeck & Co As H |
1,2,4-Triaminobenzene derivatives useful for treating disorders of the central nervous system
|
|
JP2006520333A
(ja)
|
2003-03-14 |
2006-09-07 |
ハー・ルンドベック・アクチエゼルスカベット |
置換されたアニリン誘導体
|
|
AU2004222626B2
(en)
|
2003-03-21 |
2010-06-24 |
H. Lundbeck A/S |
Substituted p-diaminobenzene derivatives
|
|
EP1631546A1
(en)
|
2003-04-25 |
2006-03-08 |
H. Lundbeck A/S |
Sustituted indoline and indole derivatives
|
|
MXPA05012463A
(es)
|
2003-05-27 |
2006-01-30 |
Altana Pharma Ag |
Combinaciones farmaceuticas de un inhibidor de bomba protonica y un compuesto que modifica la motilidad gastrointestinal.
|
|
US7276608B2
(en)
*
|
2003-07-11 |
2007-10-02 |
Bristol-Myers Squibb Company |
Tetrahydroquinoline derivatives as cannabinoid receptor modulators
|
|
EP1663239A4
(en)
|
2003-09-10 |
2008-07-23 |
Cedars Sinai Medical Center |
KALIUM CHANNEL-MEDIATED FEEDING OF MEDICINES BY THE BLOOD BRAIN BARRIER
|
|
US20050089559A1
(en)
|
2003-10-23 |
2005-04-28 |
Istvan Szelenyi |
Combinations of potassium channel openers and sodium channel inhibitors or sodium channel-influencing active compounds for treating pains
|
|
DE10359335A1
(de)
|
2003-10-23 |
2005-05-25 |
Viatris Gmbh & Co. Kg |
Kombinationen aus Kaliumkanalöffnern und Natriumkanalinhibitoren oder Natriumkanal beeinflussenden Wirkstoffen zur Behandlung von Schmerzzuständen
|
|
ES2235626B1
(es)
|
2003-11-10 |
2006-11-01 |
Almirall Prodesfarma, S.A. |
Formas de administracion masticables, no comprimidas dosificadas individualmente.
|
|
TW200530235A
(en)
*
|
2003-12-24 |
2005-09-16 |
Renovis Inc |
Bicycloheteroarylamine compounds as ion channel ligands and uses thereof
|
|
TWI349666B
(en)
|
2004-03-12 |
2011-10-01 |
Lundbeck & Co As H |
Substituted morpholine and thiomorpholine derivatives
|
|
MXPA06011807A
(es)
|
2004-04-13 |
2007-02-21 |
Icagen Inc |
Piridinas policiclicas como moduladores del canal del ion de potasio.
|
|
RU2006139930A
(ru)
|
2004-05-03 |
2008-06-10 |
Дюк Юниверсити (Сша/Сша) (Us) |
Составы для содействия снижению веса
|
|
WO2006006741A1
(ja)
*
|
2004-07-15 |
2006-01-19 |
Japan Tobacco Inc. |
縮合ベンズアミド化合物及びバニロイド受容体１型(ｖｒ１)活性阻害剤
|
|
UA89503C2
(uk)
|
2004-09-13 |
2010-02-10 |
Х. Луннбек А/С |
Заміщені похідні аніліну
|
|
KR20070057965A
(ko)
*
|
2004-09-21 |
2007-06-07 |
신타 파마슈티칼스 코프. |
염증 및 면역 관련 용도를 위한 화합물
|
|
WO2006054513A1
(ja)
|
2004-11-19 |
2006-05-26 |
Kissei Pharmaceutical Co., Ltd. |
神経因性疼痛の予防又は治療剤
|
|
EP1688141A1
(en)
|
2005-01-31 |
2006-08-09 |
elbion AG |
The use of flupirtine for the treatment of overactive bladder and associated diseases, and for the treatment of irritable bowel syndrome
|
|
US7812020B2
(en)
|
2005-03-03 |
2010-10-12 |
H. Lundbeck A/S |
Substituted pyridine derivatives
|
|
US7683058B2
(en)
|
2005-09-09 |
2010-03-23 |
H. Lundbeck A/S |
Substituted pyrimidine derivatives
|
|
WO2007050348A2
(en)
*
|
2005-10-21 |
2007-05-03 |
Merck & Co., Inc. |
Potassium channel inhibitors
|
|
ES2420960T3
(es)
|
2006-08-23 |
2013-08-28 |
Valeant Pharmaceuticals International |
Derivados de 4-(N-azacicloalquil)anilidas como moduladores de los canales de potasio
|
|
AU2007325629A1
(en)
|
2006-11-28 |
2008-06-05 |
Valeant Pharmaceuticals International |
1,4 diamino bicyclic retigabine analogues as potassium channel modulators
|
|
US8563566B2
(en)
*
|
2007-08-01 |
2013-10-22 |
Valeant Pharmaceuticals International |
Naphthyridine derivatives as potassium channel modulators
|
|
US9096518B2
(en)
*
|
2009-06-22 |
2015-08-04 |
Millennium Pharmaceuticals, Inc. |
Substituted hydroxamic acids and uses thereof
|